Comparative Effectiveness Review Number 215: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults

This resource was selected by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.

The purpose of this comparative effectiveness review is to assess adverse events of antidepressants in the treatment of major depressive disorder in adults 65 and older.


  • Was this Helpful ?
  • YesNo

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.